search
Back to results

Study of Proteins in Head and Neck Cancer Cells

Primary Purpose

Head and Neck Cancer

Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Southern blotting
TdT-mediated dUTP nick end labeling assay
gene expression analysis
protein expression analysis
flow cytometry
fluorescent antibody technique
immunoenzyme technique
immunohistochemistry staining method
immunologic technique
Sponsored by
Vanderbilt University Medical Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Head and Neck Cancer focused on measuring head and neck cancer

Eligibility Criteria

undefined - 120 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

DISEASE CHARACTERISTICS:

  • Head and neck cancer tumor cell line

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Sites / Locations

  • Vanderbilt-Ingram Cancer Center - Cool Springs
  • Vanderbilt-Ingram Cancer Center at Franklin
  • Vanderbilt-Ingram Cancer Center

Outcomes

Primary Outcome Measures

Function and mechanism of LZAP in regulating ARF
Mechanism and biological consequences of LZAP inhibition of NF-κB
Determination of LZAP tumor suppressor activity

Secondary Outcome Measures

Full Information

First Posted
May 9, 2009
Last Updated
March 10, 2017
Sponsor
Vanderbilt University Medical Center
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00896948
Brief Title
Study of Proteins in Head and Neck Cancer Cells
Official Title
Novel Protein Regulator of Tumor Suppressor ARF & NF-κB
Study Type
Observational

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
May 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vanderbilt University Medical Center
Collaborators
National Cancer Institute (NCI)

4. Oversight

5. Study Description

Brief Summary
RATIONALE: Studying proteins in head and neck cancer cells in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at proteins in head and neck cancer cells.
Detailed Description
OBJECTIVES: Define the function and mechanism of LZAP in regulating ARF. Determine the mechanism and biological consequences of LZAP inhibition of NF-κB. Determine if LZAP has tumor suppressor activity by conditional targeting of LZAP in mice. OUTLINE: Using molecular laboratory techniques, this study examines the biochemical mechanisms by which LZAP activates transcriptional, tumor suppressive activity (both p53-dependent and p53-independent) of ARF and inhibits transcriptional, tumorigenic activity of NF-kB. LZAP regulation of newly identified ARF activities, such as S-phase delay and ARF-mediated B23 degradation are also evaluated. LZAP's tumor suppressive activity is assessed in vivo using a conditional knockout vector to target LZAP in mice and to observe for spontaneous and induced tumor formation. Laboratory analyses used to determine study endpoints include standard recombinant DNA, recombinant protein expression and purification, cell culture and transfection, cell labeling, reporter assays, flow cytometry, yeast-two hybrid, immunoprecipitation, immunoblotting, immunofluorescence, TUNEL assay, ELISA assay, Southern blotting, and protein and gene expression.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Cancer
Keywords
head and neck cancer

7. Study Design

8. Arms, Groups, and Interventions

Intervention Type
Genetic
Intervention Name(s)
Southern blotting
Intervention Type
Genetic
Intervention Name(s)
TdT-mediated dUTP nick end labeling assay
Intervention Type
Genetic
Intervention Name(s)
gene expression analysis
Intervention Type
Genetic
Intervention Name(s)
protein expression analysis
Intervention Type
Other
Intervention Name(s)
flow cytometry
Intervention Type
Other
Intervention Name(s)
fluorescent antibody technique
Intervention Type
Other
Intervention Name(s)
immunoenzyme technique
Intervention Type
Other
Intervention Name(s)
immunohistochemistry staining method
Intervention Type
Other
Intervention Name(s)
immunologic technique
Primary Outcome Measure Information:
Title
Function and mechanism of LZAP in regulating ARF
Title
Mechanism and biological consequences of LZAP inhibition of NF-κB
Title
Determination of LZAP tumor suppressor activity

10. Eligibility

Sex
All
Maximum Age & Unit of Time
120 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
DISEASE CHARACTERISTICS: Head and neck cancer tumor cell line PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wendell G. Yarbrough, MD, FACS
Organizational Affiliation
Vanderbilt-Ingram Cancer Center
Official's Role
Study Chair
Facility Information:
Facility Name
Vanderbilt-Ingram Cancer Center - Cool Springs
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37064
Country
United States
Facility Name
Vanderbilt-Ingram Cancer Center at Franklin
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37064
Country
United States
Facility Name
Vanderbilt-Ingram Cancer Center
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37232-6838
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Study of Proteins in Head and Neck Cancer Cells

We'll reach out to this number within 24 hrs